On August 19, Gelonghui: Giant Star Medical (2393.HK) surged 123.68% to HKD 0.085 in early trading, but the gain quickly narrowed to around 70%. However, it remains the stock with the largest increase in the Hong Kong stock market, but the trading volume is light, with only HKD 2.67 million turnover so far. The Group announced that its comprehensive net profit for the first half of the year is estimated to increase by no less than CNY 1.05 billion, or CNY 11.6 million, due to the redemption of the original 2026 maturity preference notes at a discount, which confirmed a considerable premium. At the same time, the redemption of relevant preference notes reduced financial costs.
港股异动丨巨星医疗一度飙升123%，发盈喜预计中期纯利大增
Hong Kong stocks soared with Star Creep Medical jumping by 123%, expecting a significant increase in mid-term net profit.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.